Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.
about
[Procalcitonin as a tool for the assessment of successful therapy of severe sepsis : An analysis using clinical routine data].Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.Using Procalcitonin to Guide Antibiotic Therapy.Monitoring treatment response in abdominal sepsis with procalcitonin--if only!Predicting treatment failure in severe sepsis and septic shock: looking for the Holy GrailProcalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-upPrognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsisSerum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study.Year in review 2013: Critical Care--sepsis.Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections.Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis.Procalcitonin Kinetics in the First 72 Hours Predicts 30-Day Mortality in Severely Ill Septic Patients Admitted to an Intermediate Care UnitThe utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE studyProcalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis.Rapid diagnosis of sepsis.The management of severe community acquired pneumonia in the intensive care unit.The bacterial pneumonias: a new treatment paradigm.Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study.Determining the Clinical Utility of an Absolute Procalcitonin Value for Predicting a Positive Culture Result.Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit.Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis.Procalcitonin: The right answer but to which question?Cell-free DNA increase over first 48 hours in emergency intensive care unit predicts fatal outcome in patients with shock.Use of procalcitonin, C-reactive protein and white blood cell count to distinguish between lower limb erysipelas and deep vein thrombosis in the emergency department: A prospective observational study.Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trial.Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study.Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).Expression of CD64 on neutrophils can be used to predict the severity of bloodstream infection before broad range 16S rRNA PCR.Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia.Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients.Effect of interleukin-31 on septic shock through regulating inflammasomes and interleukin-1β.Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational studyEffect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trialsEvaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis
P2860
Q31112286-F890359B-6DBF-4B99-9B6C-CDF03389A9D5Q33557838-C32887BC-957E-4E63-B42B-431E651CF363Q33629591-0EC810B5-BBF4-4E5F-B686-C61033E3A3D8Q33752801-09C7F2B2-72BE-4C98-A549-425682A44D74Q33753353-45A65E54-FCAC-4F80-B756-37E0810151F6Q34271299-E5A7972E-8D93-45BD-939E-F9BC5E1535CCQ34500700-D0B73C87-15CB-46D6-93ED-F8B4CCDA0B33Q34612152-DA6B97AE-D0B5-40D3-A25D-E7D61E2F8582Q35091080-FF00AAE5-03E6-47E9-B6C6-3D8BD864E32DQ35156585-CF29F61F-C27D-4BE8-BAB7-7F0704289623Q35226677-CD93B172-5032-4BD1-90A9-526BF3B8D977Q35234151-B9C2AF36-D672-42A8-8A69-0B3DD1E64F1AQ35663942-E99BE040-1471-42C7-837F-A797D92D5505Q35910746-C5289640-A981-4130-ADE6-36B1AC436BF4Q36131387-867BAEB4-1968-4E59-BCD5-571DDFC82D1CQ36222704-904D6A88-76C3-45FF-8C88-BC431E7B51C8Q37639927-B305A59F-325A-4D6F-B20B-F0CE44CC2C1CQ38171058-CBB9C200-6A10-46FD-B10F-05AA8A7C7704Q38212536-5C2ACED2-926F-491E-A013-84FF46524109Q38307688-A165D9D0-D5E3-49E0-AE52-86D979D85318Q38545824-3838167C-8E95-4BC6-B9F7-D22B62B5A02AQ38963373-BEC41598-A1B4-46ED-8C8B-C1D5CF87233CQ40074249-404E224E-46CD-49CF-87CA-F1208682B4BAQ40237535-D7B1141E-1D33-4E72-9D83-ED93AA423F7AQ40252197-8F326B1D-69B4-4514-BB11-0A51C4E14E6BQ40662992-D0793FDC-5254-4251-A3FA-2563BD836FEFQ40931324-ADB9C412-15FE-4710-B30A-78D52E3410D3Q40970863-2D4C66B3-F49C-4E26-A097-F0EFAB09CD13Q41016892-434E887E-B1CF-472F-A42F-7FE97859FF0DQ41099789-25B0338E-4C53-4573-A8E8-31E523A2B28DQ41727236-9E4A93C1-0481-44B6-B062-4269BD91A2F6Q41893491-783B2F01-8ED0-4BA4-8905-2559DEA23F9FQ52611408-6C2AEA77-1912-4D79-8951-F4B83938119AQ55296740-881868EE-2924-4269-AF45-1B107046F49CQ58763790-33A03D2C-590B-4677-A482-26824313BF31Q58779035-D7E79216-F7BD-45B0-B698-093108F64176Q59127229-27013920-9484-47A2-94FD-A307F3CF4203
P2860
Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@ast
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@en
type
label
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@ast
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@en
prefLabel
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@ast
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@en
P2093
P2860
P356
P1433
P1476
Procalcitonin decrease over 72 ...... al outcome in sepsis patients.
@en
P2093
Devendra N Amin
Eric Gluck
Paula Maurer
Philipp Schuetz
Vikas Punjabi
P2860
P2888
P356
10.1186/CC12787
P577
2013-06-20T00:00:00Z
P5875
P6179
1022151447